These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32620787)

  • 21. SARS-CoV-2 renal tropism associates with acute kidney injury.
    Braun F; Lütgehetmann M; Pfefferle S; Wong MN; Carsten A; Lindenmeyer MT; Nörz D; Heinrich F; Meißner K; Wichmann D; Kluge S; Gross O; Pueschel K; Schröder AS; Edler C; Aepfelbacher M; Puelles VG; Huber TB
    Lancet; 2020 Aug; 396(10251):597-598. PubMed ID: 32818439
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Li J; Gong X; Wang Z; Chen R; Li T; Zeng D; Li M
    Virus Res; 2020 Sep; 286():198043. PubMed ID: 32502551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
    Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
    J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
    Kong Y; Wang Y; Wu X; Han J; Li G; Hua M; Han K; Zhang H; Li A; Zeng H
    Signal Transduct Target Ther; 2020 Sep; 5(1):192. PubMed ID: 32895366
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.
    Wang K; Liu Y; Hu T; Liu Y; Liu C
    Lung Cancer; 2020 Aug; 146():373-375. PubMed ID: 32563532
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 29. Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis.
    Chen YT; Shao SC; Lai EC; Hung MJ; Chen YC
    Crit Care; 2020 Jul; 24(1):439. PubMed ID: 32677972
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
    de Groot NG; Bontrop RE
    Immunogenetics; 2020 Jul; 72(5):275-277. PubMed ID: 32342146
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
    Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Kidney Injury in COVID-19: Another Challenge for Nephrology.
    Rudnick MR; Hilburg R
    Am J Nephrol; 2020; 51(10):761-763. PubMed ID: 33059350
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.
    Monneret G; de Marignan D; Coudereau R; Bernet C; Ader F; Frobert E; Gossez M; Viel S; Venet F; Wallet F
    Cell Mol Immunol; 2020 Sep; 17(9):1001-1003. PubMed ID: 32728202
    [No Abstract]   [Full Text] [Related]  

  • 34. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
    Lv W; Wu M; Ren Y; Zeng N; Deng P; Zeng H; Zhang Q; Wu Y
    J Urol; 2020 Nov; 204(5):918-925. PubMed ID: 32693711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19.
    Wang L; Foer D; Bates DW; Boyce JA; Zhou L
    J Allergy Clin Immunol; 2020 Oct; 146(4):808-812. PubMed ID: 32735807
    [No Abstract]   [Full Text] [Related]  

  • 36. The coronavirus pandemic in five powerful charts.
    Callaway E; Cyranoski D; Mallapaty S; Stoye E; Tollefson J
    Nature; 2020 Mar; 579(7800):482-483. PubMed ID: 32203366
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia.
    Tian J; Xu Q; Liu S; Mao L; Wang M; Hou X
    Curr Med Res Opin; 2020 Nov; 36(11):1747-1752. PubMed ID: 32986475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Septic shock presentation in adolescents with COVID-19.
    Dallan C; Romano F; Siebert J; Politi S; Lacroix L; Sahyoun C
    Lancet Child Adolesc Health; 2020 Jul; 4(7):e21-e23. PubMed ID: 32442421
    [No Abstract]   [Full Text] [Related]  

  • 40. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients.
    Volff M; Tonon D; Bourenne J; Simeone P; Velly L
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):577-578. PubMed ID: 32659455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.